rs377422691
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_006267.5(RANBP2):c.7066G>A(p.Asp2356Asn) variant causes a missense change. The variant allele was found at a frequency of 0.0000323 in 1,611,822 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_006267.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000191 AC: 29AN: 152126Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000363 AC: 9AN: 247960Hom.: 0 AF XY: 0.0000371 AC XY: 5AN XY: 134906
GnomAD4 exome AF: 0.0000158 AC: 23AN: 1459696Hom.: 0 Cov.: 33 AF XY: 0.0000110 AC XY: 8AN XY: 726154
GnomAD4 genome AF: 0.000191 AC: 29AN: 152126Hom.: 0 Cov.: 32 AF XY: 0.000215 AC XY: 16AN XY: 74310
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.7066G>A (p.D2356N) alteration is located in exon 20 (coding exon 20) of the RANBP2 gene. This alteration results from a G to A substitution at nucleotide position 7066, causing the aspartic acid (D) at amino acid position 2356 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Familial acute necrotizing encephalopathy Uncertain:1
This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 2356 of the RANBP2 protein (p.Asp2356Asn). This variant is present in population databases (rs377422691, gnomAD 0.06%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with RANBP2-related conditions. ClinVar contains an entry for this variant (Variation ID: 469481). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C15"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at